Correction of Figure Data in Original Investigation
Overview
A correction was made to the P value for structural valve deterioration in the PARTNER 3 trial, changing it from .89 to .88. This correction was published online on June 24, 2026, and included in the August 2026 print issue.
Background
Accurate reporting of clinical trial data is crucial for informed decision-making in healthcare. The PARTNER 3 trial provides insights into the durability of transcatheter versus surgical aortic valve replacement.
Data Highlights
No numerical or trial data presented in the source material.
Key Findings
- The P value for structural valve deterioration in the PARTNER 3 trial was corrected from .89 to .88.
- The correction was published online on June 24, 2026.
- The corrected data was included in the August 2026 print issue of the journal.
- Figures 2 and 3 in the original article were displayed larger than intended, affecting layout.
- Accurate figure representation is essential for clarity in clinical reporting.
Clinical Implications
Clinicians should be aware of the importance of accurate data representation in clinical trials.
Conclusion
The correction of the P value in the PARTNER 3 trial highlights the importance of accuracy in published clinical data.
Related Resources & Content
- JAMA Cardiology, 2026 -- Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial
- Erratum: 3D Reconstruction from Microscopic Imaging for Computer-Assisted Eye Surgery
- Journal of Neuro-Oncology — Correction: Influence of Instrumentation Material on Local Recurrence Rates in a Matched Case Series Comparing Carbon Fiber-PEEK and Titanium
- European Radiology — Reevaluation of a Decade of Gadolinium Retention and Deposition: Insights from ESMRMB-GREC
- Journal of Neuro-Oncology (Springer) — Erratum: Evaluating Phosphoenolpyruvate Carboxykinase 2 as a Prognostic Indicator: Its Expression and Clinical Relevance in Group 3 and Group 4 Medulloblastoma
- 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease
- Transcatheter Aortic Valve Implantation: Durability and Management of Valve Failure - American College of Cardiology
- oup.silverchair-cdn.com
- Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial | Trials | JAMA Cardiology | JAMA Network
- Placement of Aortic Transcatheter Valves 3 - American College of Cardiology
- Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | JACC
- Transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis: a systematic review and meta-analysis | BMC Cardiovascular Disorders | Springer Nature Link
- Long-term valve durability and clinical outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients: a systematic review and meta-analysis of randomized trials - PubMed
Based on findings from:
Error in Figure
Jama Cardiology, 2026.
https://jamanetwork.com/journals/jamacardiology/fullarticle/2852881
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
